Pherecydes Pharma
ALPHE | PA
Overview
Corporate Details
- ISIN(s):
- FR0011651694
- LEI:
- 894500LYT3UUN58X3I68
- Country:
- France
- Address:
- 22 BD BENONI GOULLIN, NANTES BIOTECH, 44200 NANTES
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Pherecydes Pharma, founded in 2006, is a clinical-stage biotechnology company specializing in the development of treatments for resistant and complex bacterial infections. The company's core activity is phage therapy, an approach that utilizes bacteriophages—natural viruses that prey on bacteria—to combat pathogens that are unresponsive to conventional antibiotics. Pherecydes Pharma focuses on a proprietary concept of 'precision phagotherapy,' which involves identifying and selecting the most effective phages from its extensive library to create personalized treatments tailored to a patient's specific bacterial strain. This targeted strategy aims to address critical unmet medical needs in treating severe infections.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Pherecydes Pharma.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2023-06-23 20:45 |
Post-Annual General Meeting Information
Informations privilégiées / Autres communiqués
|
French | 214.3 KB | |
| 2023-06-23 20:45 |
Post-Annual General Meeting Information
Inside Information / Other news releases
|
English | 213.8 KB | |
| 2023-06-14 20:00 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 197.1 KB | |
| 2023-06-14 20:00 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 200.6 KB | |
| 2023-06-08 07:30 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 297.3 KB | |
| 2023-06-08 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 269.4 KB | |
| 2023-06-05 08:00 |
Legal Proceedings Report
Inside Information / Other news releases
|
English | 198.4 KB | |
| 2023-06-05 08:00 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 192.1 KB | |
| 2023-06-02 20:00 |
Pre-Annual General Meeting Information
Modalités de mise à disposition des documents préparatoires à l'AG
|
French | 152.4 KB | |
| 2023-05-23 23:43 |
M&A Activity
News releases during takeover bids / Takeover bids Other news releases
|
English | 191.8 KB | |
| 2023-05-23 23:43 |
Registration Form
Communiqués publiés en période d'offre publique d'acquisition / OPA Autres comm…
|
French | 184.9 KB | |
| 2023-05-16 07:00 |
M&A Activity
Inside Information / Other news releases
|
English | 224.2 KB | |
| 2023-05-16 07:00 |
M&A Activity
Informations privilégiées / Autres communiqués
|
French | 216.3 KB | |
| 2023-05-11 18:00 |
Capital/Financing Update
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 200.6 KB | |
| 2023-04-27 18:00 |
Report Publication Announcement
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rap…
|
French | 195.2 KB |
Automate Your Workflow. Get a real-time feed of all Pherecydes Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Pherecydes Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
